Search
Polaris Consulting principal Geoff Pocock serves as Ostepore’s executive director.

262% share price rise for Perth biotech after IPO

Singapore and Perth-based biotech company Osteopore has begun life on the ASX today with a sharp share price surge, following a $5.25 million initial public offering.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Osteopore (OSX)

Share Price

Closing price for the last 90 trading days
Powered by Morningstar ®

Total Shareholder Return as at 29/11/19

1 year TSR5 year TSR
thOsteopore
733 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®